Kimberly Edwards-Swanson Selected Research

alcaftadine

4/2011	Clinical pharmacology of alcaftadine, a novel antihistamine for the prevention of allergic conjunctivitis.
1/2011	Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kimberly Edwards-Swanson Research Topics

Disease

2	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 04/2011 - 01/2011
1	Pruritus (Itching) 01/2011

Drug/Important Bio-Agent (IBA)

2	Ophthalmic Solutions (Eye Drops)IBA 04/2011 - 01/2011
2	alcaftadine FDA Link 04/2011 - 01/2011
1	Pharmaceutical PreparationsIBA 04/2011
1	Histamine Antagonists (Antihistamines)IBA 04/2011
1	Olopatadine Hydrochloride (Patanol)FDA Link 01/2011
1	AllergensIBA 01/2011